Document is current
Any future updates will be listed below
-
Authors
Loffroy, Romaric https://orcid.org/0000-0002-3107-5967
Guillen, Kévin
Chevallier, Olivier
Fouad, Mohamed
Couloumy, Emilie
Dencausse, Anne
Robert, Philippe
Catoen, Sarah
Salsac, Anne-Virginie
Aho-Glele, Serge Ludwig
Comby, Pierre-Olivier
- License Information
-
More Information
Article History
Received: 17 March 2025
Accepted: 7 April 2025
First Online: 22 April 2025
Declarations
:
: The study protocol was approved by the local animal experimentation ethics committee (CEEA n°106, #25592) on 23rd June 2020. The animals were housed and studied in a laboratory accredited by the French Ministry of Health for research on animal models. Requirements set forth in the 2019 updated version of the European Directive 2010/63/EU for the protection of animals used for scientific purposes were followed. Consent does not apply to this study.
: Not applicable.
: The experiments were performed at the R&D Department of the Guerbet Corporation. The rabbits and Lipiodol® Ultra Fluid were founded by Guerbet (Villepinte, France). Guerbet had no role in data collection, analysis, or interpretation, manuscript drafting or revision. EC, AD, PR, SC are employees of Guerbet. RL serves as a consultant for Guerbet and GEM Srl. The other authors declare no conflict of interest.
